Grothey Grapples With Treatment Options in mCRC
Pharma & biotech2018-06-26
17 Views
Axel Grothey, MD, discusses sidedness and first- and second-line treatments for patients with metastatic colorectal cancer.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Regeneron Pharmaceuticals' (Nasdaq: REGN) REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization
